A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects

Clinical trial NCT06548932 · COMPLETED

Trial details

NCT number: NCT06548932
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-06-30
Primary completion: 2023-02-24
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.